fda tirzepatide shortage resolved oct 2 2024 Zepbound, Mounjaro shortages are resolved, confirms Mounjaro will remain off shortage

These treatments are currently undergoing clinical trials for expanded usage in pediatric populations and to target broader cardiometabolic and liver conditions, thus rapidly expanding the treatable patient pool

These days, it has gained attention due to increasing insomnia reports by many patients

Despite the FDAs warning that unapproved incretin drugs such as compounded semaglutide and tirzepatide can be risky, their popularity too was reflected in the study

doi: 10.1016/j.taap.2009.11.017

Not every telehealth weight loss provider bothers with this certification, and the ones that skip it should raise questions

Neither treatment affected preference for alcohol, water intake or total fluid intake (Figures 3IK)